Pulmonary infections after bone marrow transplantation: clinical and radiographic findings

A N Leung1, M V Gosselin, C H Napper

  • 1Department of Radiology, Stanford University Medical Center, CA 94305-5105, USA.

Radiology
|April 20, 1999
PubMed
Abstract

Insights

Pulmonary infections in bone marrow transplant recipients are often caused by opportunistic pathogens like Cytomegalovirus and Aspergillus. These infections, diagnosed invasively, are linked to increased mortality rates.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Pulmonology

Background:

  • Bone marrow transplantation (BMT) recipients are immunocompromised, increasing susceptibility to opportunistic infections.
  • Pulmonary infections are a significant cause of morbidity and mortality in BMT patients.
  • Early and accurate diagnosis of pulmonary infections is crucial for effective management.

Purpose of the Study:

  • To evaluate clinical and radiographic features of pulmonary infections in BMT recipients diagnosed via invasive methods.
  • To identify common pathogens, their timing, and associated radiographic patterns.
  • To assess the impact of pulmonary infections on survival outcomes.

Main Methods:

  • A retrospective review of 725 adult BMT recipients was conducted.
  • Fifty-nine episodes of pulmonary infection diagnosed through invasive procedures were analyzed.
  • Data collected included causative organisms, timing of diagnosis, radiographic findings, and mortality rates.

Main Results:

  • Cytomegalovirus (CMV) and Aspergillus species were the most frequent pathogens.
  • Fungal infections predominated early post-transplant (days 0-30), while viral infections (especially CMV) were more common later (days 31-100).
  • CMV pneumonia presented with various radiographic patterns, including normal findings, while invasive aspergillosis often showed nodules or masses. Pulmonary infection was associated with significantly lower event-free survival (P < .001).

Conclusions:

  • Opportunistic pathogens are the primary cause of pulmonary infections in BMT recipients, manifesting predictably post-transplant.
  • CMV is the most common pathogen, with diverse radiographic presentations.
  • Pulmonary infections significantly increase mortality risk in BMT survivors.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...